hf 2022: helios-a: phase 3 study of vutrisiran in patients with hattr amyloidosis | dr garcia-pavia
Published 2 years ago • 447 plays • Length 4:43Download video MP4
Download video MP3
Similar videos
-
6:39
tct 2022: the partner 3 trial: sapien 3 ultra thv for failed aortic bioprosthetic valves | dr garcia
-
6:00
beyond the horizon: helios clinical trials in attr cardiomyopathy
-
3:12
hfa 23: apollo-b: patisiran treatment for cardiac amyloidosis
-
7:14
hf 2022: rebalance-hf: catheter-based ablation of the gsn in pts with hfpef | dr marat fudim
-
1:21
hf 2022: chronic & acute hf guidelines for patients: improving patient adherence | prof tiny jaarsma
-
15:38
radcliffe & cardionerds @aha22: the prevent-hd randomized clinical trial
-
5:39
nesic trial: mild and moderate claudicants benefit from nmes | prof alun davies
-
3:23
esc 2022: the pre18ffir trial: 18f-naf pet for vulnerable coronary plaque imaging after mi
-
8:15
hfsa 2022: findings from the hearo™ community study | dr william t abraham
-
5:17
linc 2022: auryon-sce: real-world cohort shows promising freedom from tlr at 6m
-
8:42
ash 22 | al amyloidosis highlights
-
2:59
linc 2022: biomimics 3d stent with dr lichtenberg: safety and efficacy in real-world patients
-
2:37
iset 2022: in.pact outcomes in patients with cli | dr thomas zeller
-
4:29
linc 2022: gpx embolic device in peripheral applications with dr andrew holden
-
5:33
linc 2022: jet-ranger: jetstream atherectomy & dcb in pts with complex calcified lesions
-
57:38
sf: "evolutionary hologenomics"
-
5:21
linc 2022: patient selection in nivl and preventing migration in venous stenting with dr kush desai
-
1:48
ash 2022 lba: findings from the alife2 trial
-
6:56
angel-aspect results